FINWIRES · TerminalLIVE
FINWIRES

加拿大蒙特利尔银行对省级债券收益的看法

By

-- 蒙特利尔银行(BMO)表示,过去一个月,加拿大省级债券的长期收益率为正,因为加拿大政府债券(GoC)收益率基本保持稳定,而利差收窄。 该行在其5月份的“省级信用观察”报告中写道,随着预算季接近尾声,4月份省级债券的长期利差收窄了约8个基点。 加拿大央行在4月份维持利率不变,市场继续预期央行将在今年晚些时候加息,原因是担心高油价将推高并扩大加拿大的核心通胀。 BMO指出,与一年前相比,省级债券的长期收益率继续优于加拿大政府债券,尽管总回报率仅为1.5%,属于“温和”水平。 该行指出,所有省份的利差在4月份均有所收窄,没有哪个省份表现尤为突出。随着预算季的结束,由于信用评级下降,不列颠哥伦比亚省的收益率仍然落后于安大略省。 阿尔伯塔省和萨斯喀彻温省在伊朗冲突推高油价之前提交了预算案,但市场已将两省的利差收窄至与安大略省的水平,BMO补充道。魁北克省由于今年秋季政治周期充满不确定性,其油价仍落后于安大略省。

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE